Clinical Trial Update: "QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes the Quad Shot radiotherapy regimen combined with pembrolizumab for recurrent head and neck cancer; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Oklahoma | Conditions: Head and Neck Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING